Literature DB >> 24354012

SUMOylation in neuroplasticity and neurological disorders.

Marco Feligioni, Mark P Mattson, Robert Nisticò.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24354012     DOI： 10.1007/s12017-013-8267-5

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN： 1535-1084            Impact factor:   3.843


× No keyword cloud information.
  7 in total

Review 1.  Protein sumoylation in brain development, neuronal morphology and spinogenesis.

Authors:  Carole Gwizdek; Frédéric Cassé; Stéphane Martin
Journal:  Neuromolecular Med       Date:  2013-08-02       Impact factor: 3.843

Review 2.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

Review 3.  SUMO: a (oxidative) stressed protein.

Authors:  Marco Feligioni; Robert Nisticò
Journal:  Neuromolecular Med       Date:  2013-09-20       Impact factor: 3.843

Review 4.  SUMO and ischemic tolerance.

Authors:  Yang-ja Lee; John M Hallenbeck
Journal:  Neuromolecular Med       Date:  2013-06-18       Impact factor: 3.843

Review 5.  Sumoylation of critical proteins in amyotrophic lateral sclerosis: emerging pathways of pathogenesis.

Authors:  Emily Foran; Lauren Rosenblum; Alexey I Bogush; Davide Trotti
Journal:  Neuromolecular Med       Date:  2013-09-24       Impact factor: 3.843

Review 6.  Proteomics strategies to identify SUMO targets and acceptor sites: a survey of RNA-binding proteins SUMOylation.

Authors:  Giuseppe Filosa; Silvia M L Barabino; Angela Bachi
Journal:  Neuromolecular Med       Date:  2013-08-25       Impact factor: 3.843

Review 7.  Receptor trafficking and the regulation of synaptic plasticity by SUMO.

Authors:  Jia Luo; Emi Ashikaga; Philip P Rubin; Michaela J Heimann; Keri L Hildick; Paul Bishop; Fatima Girach; Fernando Josa-Prado; Leo T H Tang; Ruth E Carmichael; Jeremy M Henley; Kevin A Wilkinson
Journal:  Neuromolecular Med       Date:  2013-08-11       Impact factor: 3.843
  7 in total
  2 in total

1.  SUMO1 Modification of Tau in Progressive Supranuclear Palsy.

Authors:  Hironori Takamura; Yoshiaki Nakayama; Hidefumi Ito; Taiichi Katayama; Paul E Fraser; Shinsuke Matsuzaki
Journal:  Mol Neurobiol       Date:  2022-05-14       Impact factor: 5.682

2.  SUMO1 impact on Alzheimer disease pathology in an amyloid-depositing mouse model.

Authors:  Erin Knock; Shinsuke Matsuzaki; Hironori Takamura; Kanayo Satoh; Grace Rooke; Kyung Han; Hong Zhang; Agnieszka Staniszewski; Taiichi Katayama; Ottavio Arancio; Paul E Fraser
Journal:  Neurobiol Dis       Date:  2017-12-05       Impact factor: 7.046
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.